4.8 Article

IRE1α-XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain

Journal

SCIENCE
Volume 365, Issue 6450, Pages 248-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aau6499

Keywords

-

Funding

  1. Early-Career Investigator Award of Department of Defense [W81XWH-16-1-0438]
  2. Pershing Square Sohn Cancer Research Alliance
  3. Weill Cornell Medicine Funds
  4. Department of Anesthesiology-Wake Forest School of Medicine Funds
  5. Plan Nacional de Salud y Farmacia Grant [SAF2017-83079-R]
  6. NIH [R01CA112663, 1S10OD017997-01A1]

Ask authors/readers for more resources

Inositol-requiring enzyme 1[alpha] (IRE1[alpha])-X-box binding protein spliced (XBP1) signaling maintains endoplasmic reticulum (ER) homeostasis while controlling immunometabolic processes. Yet, the physiological consequences of IRE1 alpha-XBP1 activation in leukocytes remain unexplored. We found that induction of prostaglandin-endoperoxide synthase 2 (Ptgs2/Cox-2) and prostaglandin E synthase (Ptges/mPGES-1) was compromised in IRE1 alpha-deficient myeloid cells undergoing ER stress or stimulated through pattern recognition receptors. Inducible biosynthesis of prostaglandins, including the pro-algesic mediator prostaglandin E2 (PGE(2)), was decreased in myeloid cells that lack IRE1 alpha or XBP1 but not other ER stress sensors. Functional XBP1 transactivated the human PTGS2 and PTGES genes to enable optimal PGE(2) production. Mice that lack IRE1 alpha-XBP1 in leukocytes, or that were treated with IRE1 alpha inhibitors, demonstrated reduced pain behaviors in PGE(2)-dependent models of pain. Thus. IRE1 alpha-XBP1 is a mediator of prostaglandin biosynthesis and a potential target to control pain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available